Akers Bio (AKER) continues to spike with $4.6M direct equity offering
Akers Biosciences Inc (AKER) currently trades at $6.16 and has grown by 30% today. Akers is up roughly 30% adding to yesterday’s 147% spike after it announced the advancement of its COVID-19 vaccine candidate. Akers has more recently made agreements with several institutional and accredited investors for the sale of 766,667 common shares at $6.00 per share. Gross proceeds should be $4.6M.
Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating based on current information written in this article. The high forecast for Akers Biosciences Inc is $16.00 and the low is $2.00. Notably, the company’s market cap is $16.98 million with a 52 week high of $22.32 and a 52 week low of $1.55. AKER went up $1.31 from the previous closing price of $4.69. AKER has changed in price by -15.36 per share in the last 12 months.